Cargando…

Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes

Hepatitis A virus (HAV) is a causative agent of acute hepatitis and can occasionally induce acute liver failure. However, specific potent anti-HAV drug is not available on the market currently. Thus, we investigated several novel therapeutic drugs through a drug repositioning approach, targeting rib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki-Tanaka, Reina, Shibata, Toshikatsu, Okamoto, Hiroaki, Moriyama, Mitsuhiko, Kanda, Tatsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910232/ https://www.ncbi.nlm.nih.gov/pubmed/35269774 http://dx.doi.org/10.3390/ijms23052631

Ejemplares similares

Masitinib Inhibits Hepatitis A Virus Replication
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2023)

Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus
por: Win, Nan Nwe, et al.
Publicado: (2019)

Knockdown of Mitogen-Activated Protein Kinase Kinase 3 Negatively Regulates Hepatitis A Virus Replication
por: Kanda, Tatsuo, et al.
Publicado: (2021)

Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2022)

Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells
por: Sasaki, Reina, et al.
Publicado: (2016)

Hepatitis A Virus Infection and Molecular Research
por: Kanda, Tatsuo, et al.
Publicado: (2022)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy
por: Kanda, Tatsuo, et al.
Publicado: (2023)

Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2022)

Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing
por: Ishii, Tomotaka, et al.
Publicado: (2020)

Involvement of proliferation of atypical hepatocytes and CDT 1 in the liver cancer of rats administered the diethylnitrosamine
por: Ogawa, Masahiro, et al.
Publicado: (2023)

Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression
por: Win, Nan Nwe, et al.
Publicado: (2018)

Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation
por: Jiang, Xia, et al.
Publicado: (2015)

Recent Trend of Hepatitis E Virus Infection in Chiba Area, Japan: 3 of 5 Cases with Rheumatoid Arthritis
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Hepatitis B Virus Genotype C is Predominant in Myanmar
por: Nwe Win, Nan, et al.
Publicado: (2017)

Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Bengue, Michèle, et al.
Publicado: (2021)

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
por: Sasaki, Reina, et al.
Publicado: (2019)

Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients
por: Nirei, Kazushige, et al.
Publicado: (2021)

Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma
por: Midorikawa, Yutaka, et al.
Publicado: (2019)

Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
por: Kanda, Tatsuo, et al.
Publicado: (2019)

Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication
por: Jiang, Xia, et al.
Publicado: (2017)

Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
por: Sasaki, Reina, et al.
Publicado: (2020)

Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2018)

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
por: de Ávila, Ana I., et al.
Publicado: (2016)

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan
por: Yamana, Yoichiro, et al.
Publicado: (2021)

Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
por: Masuzaki, Ryota, et al.
Publicado: (2020)

Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis
por: Kanezawa, Shini, et al.
Publicado: (2023)

Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan
por: Honda, Masayuki, et al.
Publicado: (2021)

Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer
por: Asatani, Shinya, et al.
Publicado: (2021)

Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir
por: Totsuka, Mai, et al.
Publicado: (2021)

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
por: Masuzaki, Ryota, et al.
Publicado: (2022)

MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells
por: Nakamura, Masato, et al.
Publicado: (2015)

The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma
por: Moriyama, Mitsuhiko, et al.
Publicado: (2022)

Treatment of hepatitis C virus infection in the future
por: Kanda, Tatsuo, et al.
Publicado: (2013)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p535np4sumcuplh0ua7q9dmtk3